BiotechTube
Home/Barinthus Biotherapeutics/Bill Enright
BE

Bill Enright

Chief Executive Officer & Board Director

Barinthus Biotherapeutics

Therapeutic Areas

Immunology & Inflammatory DiseasesInfectious Diseases

Barinthus Biotherapeutics Pipeline

DrugIndicationPhase
VTP-300Chronic Hepatitis BPhase 1b/2a
VTP-200Low-grade HPV-related Cervical LesionsPhase 1b/2
SNAP-based ProgramsUndisclosed Autoimmune/Inflammatory IndicationsPreclinical

Leadership Team at Barinthus Biotherapeutics

DG
Dr. Geoffrey Lynn
Chief Scientific Officer
DL
Dr. Leon Hooftman
Chief Medical Officer
RW
Robin Wright
Chairman
KD
Karen Dawes
Non-Executive Director
AH
Alex Hammacher
Non-Executive Director
DA
Dr. Anne Phillips
Non-Executive Director
View full Barinthus Biotherapeutics profile